Skip to content
Contact
News
Intranet
Merit Unit
Merit Unit
Structuring
Our quality approach
seminars
Devices in the South
Axes and projects
HOPE • Host-pathogen interactions
MEDS • Medicines: from the molecule to the market
GENE • Genetic adaptation of the host
GECO • Management, information and communication
Publications
Training
teachings
Frames
Search
Menu
Merit Unit
Merit Unit
Structuring
Our quality approach
seminars
Devices in the South
Axes and projects
HOPE • Host-pathogen interactions
MEDS • Medicines: from the molecule to the market
GENE • Genetic adaptation of the host
GECO • Management, information and communication
Publications
Training
teachings
Frames
Contact
News
Menu
Intranet
Home
»
Staff
»
Jean-Philippe CHIPPAUX
Jean-Philippe CHIPPAUX
Jean-Philippe CHIPPAUX
Emeritus Research Director
jean-philippe.chippaux@ird.fr
Other
Projects
Sorry, we did not find any items. Please try a different search.
Publications
Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms
Toxins (Basel)
(2023) 15(10):614
Impact of COVID-19 on public health in sub-Saharan Africa
Bull Acad Natl Med
(2023) 207(2):150-164 & discussion; 207(2):226-227
COVID-19 impacts on healthcare access in sub-Saharan Africa: an overview
J Venom Anim Toxins Incl Too Dis
(2023)29:e20230002
Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon
PLoS Negl Too Dis
(2023) 17(11):e0011707
Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon
PLoS Negl Too Dis
(2023) 17(11):e0011707
Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis
Lancet Microbe
(2023) 4(2):e93-e101
Defining a universal core outcome measurement set for snakebite clinical trials
Med Trop Sante Int
(2023) 3(3):mtsi.v3i3.2023.421
Snakebite Global Core Outcome Set Study Group. A global core outcome measurement set for snakebite clinical trials
Lancet Global Health
(2023) 11(2):e296-e300
«Previous
1
2
3
Vers le haut Faire défiler